3D Bioprinting with Visible Light Cross-Linkable Mucin-Hyaluronic Acid Composite Bioink for Lung Tissue Engineering
ACS Applied Bio Materials · 2024
DOI: 10.1021/acsabm.4c00579 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2024. Verfasst von Sruthi C Sasikumar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials Engineering, Indian Institute of Science Bangalore, Karnataka 560012, India. Hauptthemen laut MEDLINE: Hyaluronic Acid, Printing, Three-Dimensional, Tissue Engineering, Bioprinting. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Materials Engineering, Indian Institute of Science Bangalore, Karnataka 560012, India.
- Institute for Nanoscience and Water Sustainability, University of South Africa, the Science Campus, Florida Park, 1710 Roodepoort, Johannesburg 1735, South Africa.
ORCID-Profile: Sruthi C Sasikumar, Ashok M Raichur
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Sasikumar, S. C., Goswami, U., & Raichur, A. M. (2024). 3D Bioprinting with Visible Light Cross-Linkable Mucin-Hyaluronic Acid Composite Bioink for Lung Tissue Engineering. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.4c00579
Vancouver
Sasikumar SC, Goswami U, Raichur AM. 3D Bioprinting with Visible Light Cross-Linkable Mucin-Hyaluronic Acid Composite Bioink for Lung Tissue Engineering. ACS Applied Bio Materials. 2024. doi:10.1021/acsabm.4c00579
BibTeX
@article{Sasikumar2024,
author = {Sasikumar, Sruthi C and Goswami, Upashi and Raichur, Ashok M},
title = {3D Bioprinting with Visible Light Cross-Linkable Mucin-Hyaluronic Acid Composite Bioink for Lung Tissue Engineering},
journal = {ACS Applied Bio Materials},
year = {2024},
doi = {10.1021/acsabm.4c00579}
}
EUVIMED